Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PATH Stock Forecast 2025-2026
$12.91
Current Price
$6.95B
Market Cap
Buy 4
Hold 18
Sell 2
Wall St Analyst Ratings
Distance to PATH Price Targets
+24.9%
To High Target of $16.12
-7.0%
To Median Target of $12.00
-22.5%
To Low Target of $10.00
PATH Price Momentum
+3.3%
1 Week Change
+23.5%
1 Month Change
-36.7%
1 Year Change
+1.6%
Year-to-Date Change
-38.1%
From 52W High of $20.87
+37.6%
From 52W Low of $9.38
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching UiPath (PATH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on PATH and similar high-potential opportunities.
Latest PATH Stock Price Targets & Analyst Predictions
Based on our analysis of 26 Wall Street analysts, PATH has a neutral consensus with a median price target of $12.00 (ranging from $10.00 to $16.12). The overall analyst rating is Buy (6.3/10). Currently trading at $12.91, the median forecast implies a -7.0% downside. This outlook is supported by 4 Buy, 18 Hold, and 2 Sell ratings.
Conversely, the most conservative target is provided by Brad Sills at B of A Securities, suggesting a 22.5% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PATH Analyst Ratings
4
Buy
18
Hold
2
Sell
PATH Price Target Range
Low
$10.00
Average
$12.00
High
$16.12
Current: $12.91
Latest PATH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PATH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 15, 2025 | Mizuho | Siti Panigrahi | Neutral | Maintains | $11.00 |
| Mar 26, 2025 | RBC Capital | Matthew Hedberg | Sector Perform | Reiterates | $13.00 |
| Mar 26, 2025 | Needham | Scott Berg | Hold | Reiterates | $0.00 |
| Mar 14, 2025 | BMO Capital | Keith Bachman | Market Perform | Maintains | $11.50 |
| Mar 13, 2025 | Morgan Stanley | Sanjit Singh | Equal-Weight | Maintains | $12.00 |
| Mar 13, 2025 | B of A Securities | Brad Sills | Underperform | Downgrade | $10.00 |
| Mar 13, 2025 | UBS | Jeff Hickey | Sell | Maintains | $10.00 |
| Mar 13, 2025 | Wells Fargo | Michael Turrin | Equal-Weight | Maintains | $11.00 |
| Mar 13, 2025 | Barclays | Raimo Lenschow | Equal-Weight | Maintains | $12.00 |
| Mar 13, 2025 | Evercore ISI Group | Kirk Materne | In-Line | Maintains | $12.00 |
| Mar 13, 2025 | Mizuho | Siti Panigrahi | Neutral | Maintains | $12.00 |
| Mar 13, 2025 | Canaccord Genuity | Kingsley Crane | Buy | Maintains | $14.00 |
| Mar 13, 2025 | Needham | Scott Berg | Hold | Reiterates | $0.00 |
| Mar 13, 2025 | RBC Capital | Matthew Hedberg | Sector Perform | Maintains | $13.00 |
| Mar 13, 2025 | Scotiabank | Nick Altmann | Sector Perform | Maintains | $12.00 |
| Jan 15, 2025 | Needham | Scott Berg | Hold | Reiterates | $0.00 |
| Jan 10, 2025 | Barclays | Raimo Lenschow | Equal-Weight | Maintains | $15.00 |
| Dec 19, 2024 | Needham | Hold | Reiterates | $0.00 | |
| Dec 12, 2024 | UBS | Sell | Initiates | $0.00 | |
| Dec 6, 2024 | Barclays | Raimo Lenschow | Equal-Weight | Maintains | $16.00 |
Uipath Inc. (PATH) Competitors
The following stocks are similar to UiPath based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Uipath Inc. (PATH) Financial Data
Uipath Inc. has a market capitalization of $6.95B with a P/E ratio of -99.4x. The company generates $1.43B in trailing twelve-month revenue with a -5.2% profit margin.
Revenue growth is +4.5% quarter-over-quarter, while maintaining an operating margin of +10.1% and return on equity of -3.8%.
Valuation Metrics
Market Cap
$6.95B
Enterprise Value
$5.66B
P/E Ratio
-99.4x
PEG Ratio
29.5x
Price/Sales
4.9x
Growth & Margins
Revenue Growth (YoY)
+4.5%
Gross Margin
+84.8%
Operating Margin
+10.1%
Net Margin
-5.2%
EPS Growth
+52.7%
Financial Health
Cash/Price Ratio
+22.9%
Current Ratio
2.9x
Debt/Equity
4.2x
ROE
-3.8%
ROA
-3.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Uipath Inc. (PATH) Business Model
About Uipath Inc.
What They Do
Provides robotic process automation software solutions.
Business Model
The company generates revenue by offering a subscription-based model for its automation platform, allowing businesses to access its tools and services for automating tasks. This model enables UiPath to serve a diverse range of industries and scale its operations as clients integrate automation into their workflows.
Additional Information
Founded in 2005 and headquartered in New York, UiPath has established itself as a leader in the RPA market, assisting organizations in enhancing efficiency and driving digital transformation. Its platform includes features for analytics, artificial intelligence, and machine learning, positioning it as a comprehensive solution for operational optimization.
Company Information
Sector
Technology
Industry
Software - Infrastructure
Employees
3,868
CEO
Mr. Daniel Solomon Dines
Country
United States
IPO Year
2021
Website
www.uipath.comUipath Inc. (PATH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
SurgePays, Inc. (SURG) Reports Q1 Loss, Tops Revenue Estimates
SurgePays, Inc. (SURG) delivered earnings and revenue surprises of 5% and 9.78%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 13, 2025
By Zacks Equity Research
Tale of the Tape
UiPath (PATH) Outperforms Broader Market: What You Need to Know
The latest trading day saw UiPath (PATH) settling at $13.26, representing a +1.3% change from its previous close.
May 13, 2025
By Zacks Equity Research
Tale of the Tape
C3.ai vs. UiPath: Which AI Automation Stock Is the Better Buy in 2025?
Both are riding the AI wave, but only one is proving it with profits. Which stock stands stronger in 2025?
May 13, 2025
By Shrabana Mukherjee
Analyst Blog
Latest News
Cathay Scales Up to Meet Increased Travel Demand with Enterprise AI and Automation from UiPath
3 days ago
Quick Summary
UiPath is assisting Cathay in enhancing its digital leadership by implementing AI-powered automation solutions.
Why It Matters
UiPath's partnership with Cathay enhances operational efficiency and competitiveness, potentially increasing revenue and market share, which may positively impact UiPath's stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
UiPath (PATH) is currently gaining attention from Zacks.com users, indicating potential interest in the stock's performance and future outlook.
Why It Matters
Increased attention on UiPath (PATH) may signal potential volatility or investment opportunities, influencing stock performance and market sentiment.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
UiPath (PATH) closed at $13.26, up 1.3% from the previous trading day.
Why It Matters
UiPath's slight gain indicates positive market sentiment, potentially influencing future trading decisions and reflecting investor confidence in the company's performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
UiPath has been recognized as a Leader in the IDC MarketScape: Worldwide Business Automation Platforms 2025 Vendor Assessment, highlighting its strong position in the automation market.
Why It Matters
UiPath's recognition as a leader in business automation enhances its market credibility, likely boosting investor confidence and potentially impacting stock performance positively.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Five mid-cap AI infrastructure stocks recommended for purchase are INOD, FIVN, PATH, IDCC, and AVAV.
Why It Matters
Mid-cap AI infrastructure stocks like INOD, FIVN, PATH, IDCC, and AVAV indicate growth potential, attracting investor interest in the booming AI sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
C3.ai focuses on enterprise AI applications like predictive maintenance, while UiPath leads in robotic process automation, advancing towards "agentic AI" solutions.
Why It Matters
C3.ai and UiPath's advancements in AI automation signal growth potential in a booming sector, influencing investment opportunities and competitive positioning in tech markets.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About PATH Stock
What is Uipath Inc.'s (PATH) stock forecast for 2025?
Based on our analysis of 26 Wall Street analysts, Uipath Inc. (PATH) has a median price target of $12.00. The highest price target is $16.12 and the lowest is $10.00.
Is PATH stock a good investment in 2025?
According to current analyst ratings, PATH has 4 Buy ratings, 18 Hold ratings, and 2 Sell ratings. The stock is currently trading at $12.91. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PATH stock?
Wall Street analysts predict PATH stock could reach $12.00 in the next 12 months. This represents a -7.0% decrease from the current price of $12.91. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Uipath Inc.'s business model?
The company generates revenue by offering a subscription-based model for its automation platform, allowing businesses to access its tools and services for automating tasks. This model enables UiPath to serve a diverse range of industries and scale its operations as clients integrate automation into their workflows.
What is the highest forecasted price for PATH Uipath Inc.?
The highest price target for PATH is $16.12 from at , which represents a 24.9% increase from the current price of $12.91.
What is the lowest forecasted price for PATH Uipath Inc.?
The lowest price target for PATH is $10.00 from Brad Sills at B of A Securities, which represents a -22.5% decrease from the current price of $12.91.
What is the overall PATH consensus from analysts for Uipath Inc.?
The overall analyst consensus for PATH is neutral. Out of 26 Wall Street analysts, 4 rate it as Buy, 18 as Hold, and 2 as Sell, with a median price target of $12.00.
How accurate are PATH stock price projections?
Stock price projections, including those for Uipath Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 6:01 PM UTC